InsiderClue
← All stocks

Johnson & Johnson

JNJ Net selling
CIK 0000200406 #269 in the set updated 17 Sep 2026
Bought (12 mo)
$257.69K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$154.85M
$0.00 on a plan · $118.38M straight out of an exercise
Sold at will
$36.47M
6 of 29 sales
Net
−$154.60M
−$36.21M against sales at will

By person

13 insiders · 34 transactions
52.6×

J. Duato holds 52.6 times base salary in stock. $84.30M of shares against $1.60M in salary for 2025.

Salary from the company's own proxy. The shares are what J. Duato last reported holding, valued at $274.74, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Duato Joaquin
CEO and Chairman of the Board
—
$66.84M (6)
−$66.84M
306,819
0.0127%
$84.30M
−15.5%
Wolk Joseph J
Exec VP, CFO
—
$21.77M (4) scheduled
−$21.77M
82,835
0.0034%
$22.76M
+20.3%
REED JOHN C
EVP, Innovative Medicine, R&D
—
$17.29M (4) scheduled
−$17.29M
24,911
0.0010%
$6.84M
+70.9%
Swanson James D.
EVP, CIO
—
$15.11M (3) scheduled
−$15.11M
25,698
0.0011%
$7.06M
+76.3%
Schmid Timothy
EVP, WW Chair, MedTech
—
$15.08M (5) scheduled
−$15.08M
26,251
0.0011%
$7.21M
+89.6%
Broadhurst Vanessa
EVP, Global Corp Affairs
—
$7.30M (2) scheduled
−$7.30M
23,003
0.0010%
$6.32M
+16.0%
Forminard Elizabeth
EVP, Chief Legal Officer
—
$4.09M (2) scheduled
−$4.09M
16,994
0.0007%
$4.67M
+103.8%
Taubert Jennifer L
EVP, WWC. Innovative Medicine
—
$3.95M (1) scheduled
−$3.95M
194,451
0.0081%
$53.42M
+25.6%
Wengel Kathryn E
EVP, Chief TO and Risk Officer
—
$2.41M (1) scheduled
−$2.41M
114,288
0.0047%
$31.40M
+38.9%
Decker Robert J
VP Corporate Controller
—
$1.01M (1) scheduled
−$1.01M
23,682
0.0010%
$6.51M
+24.8%
MORIKIS JOHN G
Director
$257.69K (1)
—
+$257.69K
1,849
<0.0001%
$507.86K
+208.9%
Mulholland Kristen
EVP, Chief HR Officer
—
—
—
19,830
0.0008%
$5.45M
+69.6%
WEINBERGER MARK A
Director
—
—
—
1,000
<0.0001%
$274.74K
—

Individual transactions

34
Insider
Date
Role
Action
Shares
Price
Amount
Schmid Timothy
2 Sep 2026
EVP, WW Chair, MedTech
Sold after exercise
22,527
$274.74
$6.19M
Schmid Timothy
2 Sep 2026
EVP, WW Chair, MedTech
Sold after exercise
11,070
$274.74
$3.04M
Taubert Jennifer L
17 Aug 2026
EVP, WWC. Innovative Medicine
Sold after exercise
15,000
$263.36
$3.95M
Duato Joaquin
13 Aug 2026
CEO and Chairman of the Board
Sold after exercise
102,315
$261.00
$26.70M
Duato Joaquin
13 Aug 2026
CEO and Chairman of the Board
Sold after exercise
20,976
$262.00
$5.50M
Forminard Elizabeth
6 Aug 2026
EVP, Chief Legal Officer
Sold after exercise
6,574
$255.93
$1.68M
Forminard Elizabeth
6 Aug 2026
EVP, Chief Legal Officer
Sold after exercise
9,344
$257.76
$2.41M
Duato Joaquin
5 Aug 2026
CEO and Chairman of the Board
Sell
6,523
$258.74
$1.69M
Duato Joaquin
5 Aug 2026
CEO and Chairman of the Board
Sell
41,957
$258.06
$10.83M
Broadhurst Vanessa
20 Jul 2026
EVP, Global Corp Affairs
Sold after exercise
23,054
$251.27
$5.79M
Wengel Kathryn E
11 Jun 2026
EVP, Chief TO and Risk Officer
Sold after exercise
10,000
$241.15
$2.41M
Decker Robert J
27 Feb 2026
VP Corporate Controller
Sold after exercise
4,075
$247.87
$1.01M
Schmid Timothy
20 Feb 2026
EVP, WW Chair, MedTech
Sell
1,322
$245.66
$324.76K
Schmid Timothy
18 Feb 2026
EVP, WW Chair, MedTech
Sold after exercise
8,998
$244.53
$2.20M
Schmid Timothy
18 Feb 2026
EVP, WW Chair, MedTech
Sold after exercise
13,625
$244.20
$3.33M
Broadhurst Vanessa
17 Feb 2026
EVP, Global Corp Affairs
Sell
6,197
$243.39
$1.51M
REED JOHN C
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
2,283
$243.00
$554.77K
REED JOHN C
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
29,927
$243.00
$7.27M
REED JOHN C
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
21,721
$243.00
$5.28M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
24,961
$242.68
$6.06M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
33,386
$242.75
$8.10M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
12,066
$242.87
$2.93M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
19,241
$242.99
$4.68M
Swanson James D.
17 Feb 2026
EVP, CIO
Sold after exercise
20,521
$242.70
$4.98M
Swanson James D.
13 Feb 2026
EVP, CIO
Sold after exercise
22,191
$243.71
$5.41M
Swanson James D.
13 Feb 2026
EVP, CIO
Sold after exercise
19,368
$243.76
$4.72M
Wengel Kathryn E
6 Feb 2026
EVP, Chief TO and Risk Officer
Exercised, kept
38,945
$101.87
$3.97M
Mulholland Kristen
6 Feb 2026
EVP, Chief HR Officer
Exercised, kept
5,625
$101.87
$573.02K
Schmid Timothy
6 Feb 2026
EVP, WW Chair, MedTech
Exercised, kept
15,571
$101.87
$1.59M
Forminard Elizabeth
5 Feb 2026
EVP, Chief Legal Officer
Exercised, kept
8,921
$129.51
$1.16M
Duato Joaquin
26 Jan 2026
CEO and Chairman of the Board
Sell indirect
48,782
$221.48
$10.80M
Duato Joaquin
26 Jan 2026
CEO and Chairman of the Board
Sell indirect
51,218
$220.99
$11.32M
MORIKIS JOHN G
26 Nov 2025
Director
Buy
1,250
$206.15
$257.69K
REED JOHN C
17 Oct 2025
EVP, Innovative Medicine, R&D
Sold after exercise
21,721
$192.71
$4.19M

What was left out

Form 4 filings counted 61
Amendments (4/A) skipped 1
Filings about a different issuer 4
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 23
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 925,666
History held since 9 Sep 2016